XML 79 R38.htm IDEA: XBRL DOCUMENT v3.24.0.1
STOCKHOLDERS’ (DEFICIT) EQUITY (Tables)
 12 Months Ended
Dec. 31, 2023
Equity [Abstract]  
Schedule of Share-based Compensation Arrangements by Share-based Payment Award
Stock-based compensation expense for the years ended December 31, 2023, 2022 and 2021 is included in the Company’s Consolidated Statements of Operations as follow:

Year Ended December 31,
202320222021
Cost of revenue$5,050 $25,779 $4,084 
Research and development1,337 22,093 1,140 
Sales and marketing4,929 9,401 836 
General and administrative1
47,576 125,621 32,877 
Total stock-based compensation expense1
$58,892 $182,894 $38,937 
1 Includes $1.0 million of stock-based compensation that was provided in severance as part of restructuring charges incurred during the year ended December 31, 2022.
Schedule of Stock Option Activity
A summary of stock option activity for the year ended December 31, 2023, is as follows (amounts in thousands, except per share amounts):
 Number of
Shares		Weighted-
Average Exercise
Price		Weighted-Average
Remaining
Contractual Term
(in years)		Aggregate
Intrinsic
Value
Options outstanding - January 1, 2023
23,915 8.64 
Granted— — 
Exercised
(3)1.44 
Forfeited(674)11.47 
        Expired
(663)6.60 
Options outstanding - December 31, 2023
22,575 $8.88 6.9$— 
Options vested and expected to vest as of December 31, 2023
22,575 $8.88 7.9$— 
Options vested and exercisable as of December 31, 2023
10,508 $7.42 5.8$— 
Schedule of Restricted Stock Units Activity
A summary of RSU activity for the year ended December 31, 2023, is as follows (amounts in thousands, except per share amounts):
Number of
Shares		Weighted-Average
Grant Date Fair
Value
Unvested - January 1, 2023
45,216 $2.79 
Granted
— — 
Vested
(217)10.11 
Forfeited
(6,641)3.18 
Unvested - December 31, 2023
38,358 $2.69